Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 7 to 11, 2022. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 7 to 11, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Excess Mortality Adds to the Toll of the COVID-19 Pandemic
FRIDAY, March 11, 2022 (HealthDay News) — The full impact of the COVID-19 pandemic in terms of excess mortality has been much greater than indicated by reported deaths due to COVID-19, according to a study published online March 10 in The Lancet.
Risk for Blood Clots After COVID-19 Vaccination Explored
FRIDAY, March 11, 2022 (HealthDay News) — There is a small increased risk for intracranial venous thrombosis, thrombocytopenia, and cerebral venous sinus thrombosis after the ChAdOx1-S COVID-19 vaccination, but not after the BNT162b2 vaccination, according to two studies published online Feb. 22 in PLOS Medicine.
Masks Reduced COVID-19 Incidence in K-12 Setting in Arkansas
THURSDAY, March 10, 2022 (HealthDay News) — Masks are important for preventing COVID-19 incidence in kindergarten through grade 12 school settings, according to research published in the March 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
U.S. Airplane, Train, and Transit Mask Mandates Extended to April 18
THURSDAY, March 10, 2022 (HealthDay News) — Mask mandates for airplanes, trains, and transit hubs that were set to expire next week will be extended to April 18, the Biden administration is expected to announce Thursday.
Survival High With ECMO for Selected Severe COVID-19 Patients
THURSDAY, March 10, 2022 (HealthDay News) — For patients with severe COVID-19, a well-defined patient selection and management strategy of venovenous extracorporeal membrane oxygenation results in high survival to discharge that is sustained at one year, according to a study published online March 10 in the Annals of Thoracic Surgery.
Secondary Transmission of SARS-CoV-2 Low in Cohort of K-12 Schools
WEDNESDAY, March 9, 2022 (HealthDay News) — In a cohort of K-12 schools, secondary transmission of severe acute respiratory syndrome coronavirus 2 was low and was reduced by universal masking, according to a study published online March 9 in Pediatrics.
Pfizer Begins Trial of COVID-19 Drug Paxlovid in Children 6 to 17 Years
WEDNESDAY, March 9, 2022 (HealthDay News) — Pfizer Inc. announced Tuesday that it has launched a phase 2/3 clinical trial of its COVID-19 antiviral pill known as Paxlovid in children ages 6 to 17 years.
Continued Dexamethasone at Discharge Not Tied to Better COVID-19 Outcomes
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy .jpg)
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy 
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
